Rocket Pharmaceuticals Inc
RCKT
Market Cap$272.58M
Close$
$1.46
42.4% downside
Current Fair Value
42.4% downsideOvervalued by 42.4% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $272.58 Million |
|---|---|
| Enterprise Value | $248.12 Million |
| Dividend Yield | $0 (0%) |
| Earnings per Share | $-2.73 |
| Beta | 0.68 |
| Outstanding Shares | 110,093,461 |
Return
| Return on Equity | - |
|---|---|
| Return on Assets | - |
| Return on Invested Capital | - |
Valuation & Multiples
| P/E Ratio | -1.08 |
|---|---|
| PEG | 93.04 |
| Price to Sales | - |
| Price to Book Ratio | 0.84 |
| Enterprise Value to Revenue | - |
| Enterprise Value to EBIT | -0.94 |
| Enterprise Value to Net Income | -1 |
| Total Debt to Enterprise | 0.1 |
| Debt to Equity | 0.06 |
Revenue Sources
No data
Insider Trades
ESG Score
No data
About Rocket Pharmaceuticals Inc
151 employees
CEO: Gaurav Shah